Autoantibodies against angiotensin II Type 1 receptor (AT1-AA) are routinely detected in the serum of preeclampsia patients, which results in an increase in vascular tone and an elevation in intracellular calcium concentration of rat vascular smooth muscle (VSM). The big conductance calcium-activated potassium channels (BK Ca channels) account for the dominant outward currents in VSMCs, contributing to membrane hyperpolarization and vasodilation. In the present study, we investigated the effect of AT1-AA on BK Ca channels. A preeclampsia model was established by passively immunizing healthy pregnant BALB/c mice with AT1-AA extracted from hybridoma culture supernatant. Blood pressure, serum AT1-AA levels, and urinary protein were measured in the immunized mice. BK Ca channel expression was detected using qRT-PCR and immunohistochemical technique. The patch-clamp technique was used to record the single currents of BK Ca channels in the HEK293T cells that had been transfected. AT1-AA immunized mice exhibited elevated AT1-AA and urinary protein levels compared with mice of the vehicle group. Systolic blood pressure was also increased in the immunized group. BK Ca channel β 1 -subunit expression was reduced in the mesenteric arteries of immunized mice. AT1-AA could inhibit the BK Ca currents and the inhibitory effects were not completely reversed following the application of valsartan, an inhibitor of AT1 receptor. In conclusion, AT1-AA could decrease BK Ca expression and inhibit BK Ca activity independent of AT1R. These inhibitory effects are likely to be contributory factors in the promotion of increased vascular tone caused by AT1-AA in preeclampsia.
Introduction
Preeclampsia occurs late in pregnancy, resulting in hypertension and proteinuria. Intensive vasospasm caused by increased vascular tone is one of the fundamental pathological changes associated with this disease [1] . Previous studies have suggested that excessive activation of Rein-angiotensin II-aldosterone system (RAAS) is responsible for the occurrence of the associated vasospasms [2] . However, other factors have also been proved to participate in these reactions. Autoantibodies against angiotensin II Type 1 receptor (AT1-AA) were initially detected in the serum of pregnant women with preeclampsia by Wallukat et al. [3] . They also demonstrated that AT1-AA exhibited an agonist-like effect via the activation of angiotensin II Type 1 receptor (AT1R). In our previous study, AT1-AA was shown to increase coronary artery constriction in rats [4] , indicating that AT1-AA facilitates an increase in vascular smooth muscle (VSM) tension. However, the mechanism underlying these effects remains to be elucidated.
Potassium and calcium currents have been shown to be important factors in mediating VSM tension. VSM contracts when stimulated by an increase in intracellular calcium concentrations following the influx of Ca 2+ through voltage-dependent L-type calcium channels. In addition, the elevated intracellular calcium concentration activates K + channels, leading to the occurrence of hyperpolarization, which subsequently limits the increase of intracellular calcium levels. Therefore, K + channels also play a vital role in regulating VSM tension. While a variety of K + channels are expressed on arterioles, the large conductance calcium-activated potassium channels (BK Ca channels) are the major regulators of arteriolar myogenic vasoconstriction. BK Ca channels consist of four structural α-subunits and four regulatory β-subunits. The α-subunits contribute to voltagesensing and pore-forming, while β-subunits regulate the sensitivity of voltage and calcium of BK Ca channels. β 1 -subunit is the predominant β-subunit in VSMCs [5] . Hu et al. [6] demonstrated that, during pregnancy, the activity of BK Ca channels is increased, while the vascular tone of uterine arteries is decreased. These results indicated the importance of BK Ca channels in the regulation of VSM tension. However, it remains to be elucidated whether AT1-AA promotes alterations in VSM tone by interacting with BK Ca channels. It has been reported that angiotensin II can inhibit BK Ca channels via activation of AT1R and the downstream protein kinase C (PKC) pathway [7, 8] , however, the effect of AT1-AA on BK Ca channels has not yet been determined. Therefore, further research is required to investigate the mechanism that underpins increased vascular tone induced by AT1-AA in preeclampsia.
In this study, BALB/c mice were used to establish the preeclampsia model to examine the pathological effects of AT1-AA. The expression and activation of BK Ca channels in model mouse were detected. In order to investigate the mechanisms that promote AT1-AA-induced hypertension, the BK Ca channel expression plasmid was transfected into HEK293T cells and the effect of AT1-AA on BK Ca channels was subsequently measured in the transfected cells using the patch-clamp technique.
Materials and Methods

Preparation of the monoclonal AT1-AA
The monoclonal AT1-AA was obtained from hybridoma culture supernatant, as previously described [9] . The hybridomas were grown in RPMI medium supplemented with 10% fetal bovine serum (Gibco, Gaithersburg, USA). After 24 h of incubation, the supernatant was removed and fresh culture medium was added to the cells. The proteins in the hybridoma culture supernatant were concentrated at a ratio of 5:1 and filtered using a 0.45-μm filter, and the IgG of the hybridoma culture supernatant was purified using a protein G affinity column. Prior to the analysis, mice were maintained in 12/12 h light/dark cycles. They were monitored three times/day. They were administered pentobarbital sodium (150 mg/kg) by intraperitoneal injection (i.p.) to reduce anxiety prior to surgical anesthesia. Upon completion of the analysis, the BALB/c mice were euthanized, followed by decapitation using a guillotine (a physical method suggested by AVMA Guidelines on Euthanasia). Healthy BALB/c pregnant mice (n = 12) were used in this study. The animals were divided into two groups. In the AT1-AA group (n = 6), monoclonal AT1-AA (1 μg/g body weight) was diluted with 200 μl of saline. This AT1-AA solution was introduced into pregnant mice at Days 13 and 15 of gestation [10] . In the vehicle group (n = 6), pregnant mice received saline only. Plasma was collected on Day 18 of gestation to measure the AT1-AA optical density (OD) value. Mouse systolic blood pressure was measured from Day 13 to Day 18 of gestation using a tail-cuff system (AD Instruments, Sydney, Australia). On Day 18 of gestation, the dams were killed and mouse urine was collected. Urinary albumin was quantified using an Enzyme-linked immunosorbent assay (ELISA) kit (Exocell, Philadelphia, USA) and urinary creatinine levels were measured using a picric acid colorimetric assay kit (Exocell). The ratio of urinary albumin to urinary creatinine was used to generate a urinary protein index [10] .
Immunization of animals
Enzyme-linked immunosorbent assay
Blood samples were collected from the caudal vein, and the serum was separated by centrifugation at 1000 g for 15 min. The AT1-AA titer was measured by ELISA. The results were expressed as OD values. The OD value was measured at 405 nm using a Spectra Max Plus microplate reader (Molecular Devices, Sunnyvale, USA). A positive/ negative (P/N) ratio for each sample was measured as follows: (OD of sample − OD of blank control)/(OD of negative control − OD of blank control). Negative control samples were prepared from healthy mice as follows: 100 sera samples with an OD value of less than 2.5-folds of the background OD were pooled and centrifuged at 250 g for 10 min. The supernatants were subsequently divided into smaller aliquots and stored at −20°C prior to use. Samples with a P/N value of ≥2.1 were considered as AT1-AA-positive, and samples with a P/N value of ≤1.5 were considered as AT1-AA-negative.
qRT-PCR
Total RNA was extracted from the mesenteric arteries of mice using Trizol reagent (Sigma-Aldrich, St Louis, USA). About 1 μg of total RNA was reverse transcribed to cDNA using PrimeScript™ II 1st Strand cDNA Synthesis kit (TaKaRa, Dalian, China) according to the manufacturer's recommendations. qPCR was performed after cDNA amplification using the primers shown in Table 1 . Gene expression levels were normalized to GAPDH and calculated by 2 −ΔCt method.
Immunohistochemistry analysis
The mesenteric arteries of mice were isolated and fixed overnight with 4% formaldehyde at room temperature. Tissues were infiltrated and embedded in paraffin. An immunohistochemical technique was used to detect the expressions of the BK Ca channels. Endogenous peroxidase activity was blocked by incubation with 3% hydrogen peroxide solution at room temperature for 10 min in the dark. Next, the sections were heated in a microwave for 15 min to facilitate antigen retrieval. Bovine serum albumin (BSA, 10%) was applied to tissues to permit blocking. Sections were incubated overnight with the appropriate primary antibody at 4°C, and subsequently incubated for 40 min with horseradish-peroxidase-labeled goat anti-rabbit IgG (Proteintech Group Inc., Chicago, USA). Anti-K Ca 1.1 and anti-sloβ1 (dilution 1:200; Alomone Labs, Jerusalem, Israel) were used as the primary antibodies. Negative control experiments were performed by substituting the primary antibody with 10% BSA.
Transfection and single-channel recording experiment
The HEK293T cell line was obtained from the China Infrastructure of Cell Line Resources (Beijing, China). Cells were grown in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C in an incubator maintained with 5% CO 2 . For the transfection of HEK293T cells, 0.8-2.4 × 10 5 cells were seeded in a 35-mm culture plate and cultured for 24 h. The pcDNA3.1-hSlo expression plasmid containing a GFP label was provided by Professor Cao JM (Peking Union Medical College, Beijing, China). The α-hSlo gene in the associated expression plasmid is known to encode a functional BK Ca channel. The expression plasmid was transfected into HEK293T cells to facilitate transient expression of the α-hSlo gene [11] . Lipofectamine 2000 reagent (Invitrogen, Carlsbad, USA) was used to perform the transfection. Transfected cells were incubated at 37°C for an additional 48 h. Single-channel recording was performed at room temperature (22-24°C) using the voltageclamp technique in a cell-attached and inside-out configuration. The internal solution contained 100 mM K-Asp, 40 mM KCl, 10 mM HEPES, and 1 mM EGTA. The pH was adjusted to 7.2 using KOH. The extracellular (bath) solution contained 40 mM K-Asp, 100 mM KCl, 10 mM HEPES, and 2 mM EGTA. The pH was adjusted to 7.4 using KOH. The solutions above are the same for both cell-attached and inside-out patches. Patch pipettes (Sutter, Novato, USA) and P-97 Flaming/Brown micropipette pullers (Sutter) were used during this experiment. The pipettes had a resistance of 10-15 MΩ. Singlechannel currents of BK Ca channels were monitored using pCLAMP9.2 software (Molecular Devices). Multi-Gaussian adjustments of the amplitude distributions between channels were used to determine single-channel currents. The single-channel open probabilities (NPo) were calculated as previously described [12] .
Statistical analysis
Data were expressed as the mean ± SEM. Statistical analysis was performed using the unpaired Student's t test or ANOVA where appropriate. The analyses were carried out using SPSS 13.0 software (SPSS, Chicago, USA). Statistical significance was set at P < 0.05.
Results
AT1-AA induces preeclampsia in pregnant mice
To observe the pathological effects of AT1-AA in vivo, pregnant mice were injected with AT1-AA extracted from hybridoma culture supernatant on Days 13 and 15 of gestation. The dams were killed on Day 18 of gestation. ELISA was used to determine serum levels of AT1-AA in pregnant mice. The OD value of AT1-AA was positive (P/N ≥ 2.1) in the immunization group, but remained negative (P/N ≤ 1.5) in the vehicle group (Fig. 1A) . Systolic blood pressure was measured from Day 13 to Day 18 of gestation. The systolic pressure remained stable during this period in the vehicle group, but increased gradually in the immunization group during the same period and peaked at Day 18 of gestation (Fig. 1B) . Proteinuria is also an important feature of preeclampsia, and can be monitored by calculating the ratio of urinary albumin to creatinine in the urine on Day 18 of gestation [10] . Results showed that there was a significant increase in the calculated ratio in the immunization group compared with that in the vehicle group (Fig. 1C) . Overall, these results indicated that AT1-AA induced some of the major features of preeclampsia in pregnant mice, such as hypertension and proteinuria.
The expression of BK Ca β 1 -subunits is decreased in the mesenteric arteries of preeclampsia mice
To explore the functions of BK Ca in the preeclampsia mouse model, the mRNA and protein level of BK Ca were measured in the mesenteric artery samples from preeclampsia mice. The expressions of β 1 subunits were significantly lower in the AT1-AA group than those in the vehicle group as revealed by qRT-PCR and immunohistochemical analysis (Fig. 2) ; however, no significant changes were detected in the α subunits between two groups. These results suggested that AT1-AA caused a reduction in the expression of BK Ca channel β 1 subunits in resistance vessel.
BK Ca activity is inhibited in the mesenteric arteries of preeclampsia mice
The function of β 1 subunit is to regulate the Ca 2+ sensitivity of BK Ca channels. The decrease of β 1 subunit in the mesenteric arteries of preeclampsia mice suggests that BK Ca activity may be inhibited. To measure the activity of BK Ca in the preeclampsia mouse model, we further detected the NPo of BK Ca in mesenteric artery VSMCs from preeclampsia mice. Our results showed that Ca 2+ sensitivity of BK Ca channels was reduced in preeclampsia mice, compared with that in the vehicle group (Fig. 3) . These results suggested that AT1-AA could decrease the Ca 2+ sensitivity of BK Ca , thereby inhibiting the activity of BK Ca in the mesenteric arteries of preeclampsia mice.
AT1-AA could inhibit BK Ca activity in HEK293T cells transfected with α-hSlo
Our results showed that β 1 subunit expression and Ca 2+ sensitivity of BK Ca were reduced in preeclampsia mice. Therefore, we speculate that AT1-AA may inhibit BK Ca activity via reducing the expression of β 1 subunit. As for the α subunit, our study found that AT1-AA could not alter its expression in resistance vessels of preeclamptic mice (data not shown), whether its activity is affected by AT1-AA has not been investigated. To investigate α subunit further, the effect of AT1-AA on BK Ca channels in HEK293T cells transfected with α-hSlo was studied. Single-channel recordings were performed in a cellattached patch configuration in symmetrical K + conditions (140 mM). The ratio of urinary albumin to creatinine in the urine on Day 18 of gestation showed a significant increase in the AT1-AA group. Data are presented as the mean ± SEM, First, the properties of BK Ca channels transfected into HEK293T cells were confirmed (Fig. 4A) . Paxilline, a specific BK Ca channel blocker, blocked the current. Angiotensin II, a known AT1R agonist, was added to the bath as a positive control and the potential was maintained at +60 mV. These results showed that angiotensin II significantly decreased the probability of channel opening (Fig. 4B) .
The application of identical doses of AT1-AA also reduced the probability of channel opening in a dose-dependent manner (Fig. 4C) . These results suggested that AT1-AA could inhibit BK Ca activity by reducing the probability of channel opening in the absence of BK Ca channel β-subunits.
AT1-AA inhibits BK Ca activity via other pathway except AT1R
Our results showed that AT1-AA could inhibit BK Ca activity. The inhibitory effect induced by AT1-AA was not completely reversed by the presence of valsartan, an AT1R blocker. Similar effects were observed after angiotensin II was applied to the bath (Fig. 4D,E) . These results suggest that AT1-AA may inhibit BK Ca activity via other pathway rather than AT1R.
Discussion
The pathological effects of AT1-AA in the development of preeclampsia have been intensively studied since its discovery in 1999 [3] . According to relevant research [10] , administration of AT1-AA during the second trimester of pregnancy (Day 13 of gestation) induces preeclampsia in mice, suggesting that AT1-AA is closely related to the development of preeclampsia. In the present study, a preeclampsia mouse model was established following passive immunization with AT1-AA extracted from hybridoma culture supernatant. On Day 18 of gestation, the defining features of preeclampsia were observed i.e. hypertension and proteinuria emergence. These characteristics indicate the probability of abnormal vascular tone occurrence.
The onset of hypertension attributes to enhanced vasoconstriction or attenuated vasodilatation. Our previous work demonstrated that AT1-AA caused significant vasoconstriction in the middle cerebral artery and coronary artery of rats through AT1R activation [4] . In addition, it has been shown that AT1-AA administration results in elevated intracellular calcium concentrations in VSMs of rats through activation of AT1R [13] . A similar increase in intracellular calcium levels (in VSM) was observed when angiotensin II was administered [14] . These studies suggested that AT1-AA increases VSM tension via activation of voltage-gate calcium channels, thereby leading to enhanced vascular tone in associated arteries.
During the regulation of VSM tension, BK Ca channels account for the dominant outward currents and play a key role in controlling vasodilatation [15] . BK Ca channels are tetrameric and consist of pore-forming α-subunits along with accessory β-subunits. The α-subunits contain a transmembrane domain, which responds to variations in voltage and Ca 2+ concentrations [16] . At least four β-subunits have been discovered [17] ; β 1 -subunits are the predominant β-subunits in VSMCs [18] , and they facilitate an increase in the sensitivity of channels to voltage and calcium concentration variations [19] . BK Ca channels can be activated by membrane depolarization and elevated intracellular Ca 2+ concentrations [20] .
During pregnancy, blood flow of uterine artery is increased, accompanied with decreased vascular tone in order to meet the fetal intrauterine growth. According to related research, an increase in both the expression and activity of BK Ca channels in uterine arteries during pregnancy is responsible for the decreased vascular tone [4] . Therefore, we hypothesize that abnormal expression and activity of BK Ca channels may be related to hypertension: the predominant symptom of preeclampsia. In this study, BK Ca was monitored in aortas and mesenteric arteries of preeclampsia mice. A significant decrease of β 1 subunits was observed in the mesenteric artery of the preeclampsia mice. However, there was no difference in aortic between the two groups. These results suggest that hypertension occurring during preeclampsia may be related to the decreased expression of BK Ca . These results also suggest that the development of preeclampsia mainly affects resistance vessels. This might help to explain why BK Ca expression was not changed in aortic.
To study the activity of BK Ca channels in preeclampsia, VSMCs of mesenteric arteries were isolated, and patch-clamp technique was used to detect the NPo of BK Ca channels. The results showed that Ca 2+ sensitivity of BK Ca channels was reduced in preeclampsia mice.
The sensitivity of BK Ca channel to Ca 2+ was regulated by the β 1 -subunits [5] . In preeclampsia model mice, AT1-AA decreased the expression of β 1 -subunits, thus reducing Ca 2+ sensitivity of BK Ca channels. To study the effect of AT1-AA on BK Ca further, the α-hSlo expression plasmid (containing a GFP label) was transfected into HEK293T cells to facilitate transient expression. In our study, the single-channel currents were recorded using the cell-attached configuration. Our results suggested that angiotensin II inhibits the activity of BK Ca . It has previously been reported that activation of PKC inhibits cAMP-induced activation of the BK Ca channels in pulmonary arterial smooth muscle of fawn-hooded rats [8] . Therefore, as an agonist of AT1R, angiotensin II might inhibit BK Ca channels through activation of AT1R and the PKC pathway. However, the mechanisms that underpin the effect of AT1-AA on BK Ca channel activity have never been shown. In the current study, we demonstrated for the first time that AT1-AA inhibited BK Ca channel activity by reducing the NPo.
Nonetheless, there are some limitations in this study. The wellknown effects of AT1-AA administration include the elevation in the levels of intracellular calcium concentrations and enhanced vasoconstriction. These effects are elicited following the activation of AT1R (AT1-AA is an agonist of AT1R). Valsartan did not completely reverse AT1-AA and angiotensin II-induced inhibition of BK Ca channels either, suggesting that AT1-AA might inhibit BK Ca channels via a non-AT1R pathway. According to the research of Toro et al. [21] , angiotensin II directly acts on BK Ca channels from coronary smooth muscle, producing a change in Ca 2+ sensitivity, thereby inhibits BK Ca activity. Therefore, we suspect that the inhibitory effect of AT1-AA on BK Ca may be induced by a direct action on BK Ca channels rather than AT1R. However, the pathway that promotes the effect of AT1-AA on BK Ca activity still needs further investigation. In summary, we demonstrated that AT1-AA inhibits the activity of BK Ca channels in HEK293T cells transfected with α-hSlo. AT1-AA also resulted in a decrease in the expression of BK Ca channels in the resistance vessels of pregnant mice, indicating that AT1-AA might be involved in abnormal increases in vascular tone during preeclampsia. However, a possible role of a non-AT1R pathway that promotes the effects of AT1-AA requires further investigations.
